Clincosm LogoSign in Get a demo

genitourinary cancer

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Severe Major Depression, Schizophrenia Trial (Virtual Cancer and Mental Health Tumor Board)

Not yet recruiting
  • Cancer
  • +8 more
  • Virtual Cancer and Mental Health Tumor Board
  • (no location specified)
Apr 26, 2023

Urothelial Cancer and Rare Genitourinary Tract Malignancies

Recruiting
  • Urothelial Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy

    Recruiting
    • Urothelial Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Breast Cancer, Gastrointestinal Cancer, Gynecologic Cancer Trial in Boston (Clinician Nudge Email, Patient Nudge Letter and

    Enrolling by invitation
    • Breast Cancer
    • +4 more
    • Clinician Nudge Email
    • Patient Nudge Letter and Share questionaire
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 19, 2022

    Integrated Molecular Profiling in Advanced Cancers Trial

    Active, not recruiting
    • Breast Cancer
    • +9 more
      • Toronto, Ontario, Canada
        Princess Margaret Hospital
      Sep 26, 2022

      Impact of COVID-19 on GU Disease

      Recruiting
      • COVID-19 Infection
      • +2 more
        • New York, New York
          Icahn School of Medicine at Mount Sinai
        Sep 13, 2022

        Metastatic Cancer, Locally Advanced Cancer, Thoracic Cancer Trial in New York (Weekly 45 minute Sessions)

        Active, not recruiting
        • Metastatic Cancer
        • +5 more
        • Weekly 45 minute Sessions
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Aug 19, 2022

        Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

        Recruiting
        • Genitourinary Cancer
        • +7 more
        • La Jolla, California
        • +5 more
        Jul 5, 2022

        Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

        Recruiting
        • Breast Cancer
        • +10 more
          • Hamilton, Ontario, Canada
          • +6 more
          Apr 21, 2022

          Circulating Tumor DNA for Early Treatment Response Assessment of

          Recruiting
          • Healthy Volunteer
          • +12 more
            • Saint Louis, Missouri
              Washington University School of Medicine
            Apr 4, 2022

            Melanoma, Colon Cancer, Gastrointestinal Cancer Trial run by the NCI (National Cancer Institute (NCI)-4650, a messenger

            Terminated
            Has Results
            • Melanoma
            • +4 more
            • National Cancer Institute (NCI)-4650, a messenger ribonucleic acid (mRNA)-based, Personalized Cancer Vaccine
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            May 22, 2020

            Genitourinary Cancer, Kidney Cancer Trial in United States (Sunitinib, Questionnaire)

            Completed
            Has Results
            • Genitourinary Cancer
            • Kidney Cancer
            • Stanford, California
            • +4 more
            Feb 14, 2020

            Breast Cancer, Gastrointestinal Cancer, Genitourinary Cancer Trial in Richmond (Doxorubicin, Sildenafil)

            Completed
            • Breast Cancer
            • +4 more
            • Richmond, Virginia
              Virginia Commonwealth University/Massey Cancer Center
            Aug 22, 2019

            Prostate Cancer, Kidney Cancer, Genitourinary Cancer Trial in Boston (Postwire)

            Completed
            • Prostate Cancer
            • +2 more
            • Postwire
            • Boston, Massachusetts
              Dana Farber Cancer Institute
            Jun 6, 2019

            Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2

            Unknown status
            • Metastatic Gastrointestinal Cancer
            • Genitourinary Cancer
              • Seoul, Korea, Republic of
                Samsung Medical Center
              May 17, 2019

              Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)

              Completed
              • Gastrointestinal Cancer
              • +8 more
                • Dallas, Texas
                  UT Southwestern Medical Center
                May 9, 2018

                Breast Cancer, Gastrointestinal Cancer, Genitourinary Cancer Trial in Toronto (GA and Integrated Care Plan)

                Completed
                • Breast Cancer
                • +2 more
                • GA and Integrated Care Plan
                • Toronto, Ontario, Canada
                  Princess Margaret Cancer Centre
                Apr 10, 2018

                Tissue Fibrosis/ Lymphatico-venous Bypass

                Completed
                • Breast Cancer
                • +4 more
                • Punch Biopsy
                • Houston, Texas
                  University of Texas MD Anderson Cancer Center
                May 5, 2015

                Bladder Cancer, Genitourinary Cancer, Prostate Cancer Trial in Houston (Ferumoxtran-10 (USPIO), MR lymphangiography)

                Terminated
                Has Results
                • Bladder Cancer
                • +2 more
                • Ferumoxtran-10 (USPIO)
                • MR lymphangiography
                • Houston, Texas
                  U.T.M.D. Anderson Cancer Center
                Jul 31, 2012